{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:44:39Z","timestamp":1791042279385,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s11883-008-0003-5","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T09:03:18Z","timestamp":1201683798000},"page":"11-18","source":"Crossref","is-referenced-by-count":20,"title":["Statins in the spectrum of neurologic disease"],"prefix":"10.1007","volume":"10","author":[{"given":"J.","family":"David Orr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,31]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/01.STR.0000147965.52712.fa","volume":"35","author":"P. Amarenco","year":"2004","unstructured":"Amarenco P, Labreuche J, Lavallee P, et al.: Statins in stroke prevention and carotid atherosclerosis systematic review and up-to-date meta-analysis. Stroke 2004, 35:2902\u20132909.","journal-title":"Stroke"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","volume":"48","author":"C.P. Cannon","year":"2006","unstructured":"Cannon CP, Steinberg BA, Murphy SA, et al.: Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006, 48:438\u2013445.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C. Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, et al.: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 2005, 366:1267\u20131278.","journal-title":"Lancet"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"S.M. Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, et al.: Implications of recent clinical trials for National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227\u2013235.","journal-title":"Circulation"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"T.A. Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, et al.: Markers of inflammation and cardiovascular disease. Circulation 2003, 107:499\u2013511.","journal-title":"Circulation"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.STR.0000201856.90105.ab","volume":"37","author":"P. Amarenco","year":"2006","unstructured":"Amarenco P, Moskowictz MA: The dynamics of statins: from event prevention to neuroprotection. Stroke 2006, 37:294\u2013296.","journal-title":"Stroke"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","volume":"4","author":"L.A. Shobab","year":"2005","unstructured":"Shobab LA, Hsiung GR, Feldman HH: Cholesterol in Alzheimer\u2019s disease. Lancet Neurol 2005, 4:841\u2013852.","journal-title":"Lancet Neurol"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jneuroim.2006.06.006","volume":"178","author":"M.S. Weber","year":"2006","unstructured":"Weber MS, Youssef S, Dunn SE, et al.: Statins in the treatment of central nervous system autoimmune disease. J Neuroimmunol 2006, 178:140\u2013148.","journal-title":"J Neuroimmunol"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrn1652","volume":"6","author":"T. Menge","year":"2005","unstructured":"Menge T, Hartung H, Stuve L: Statins: a cure-all for the brain. Nature Rev Neurosci 2005, 6:325\u2013331.","journal-title":"Nature Rev Neurosci"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","volume":"62","author":"M. Inglesson","year":"2004","unstructured":"Inglesson M, Fukumoto H, Newell KC, et al.: Early A-beta accumulation and progressive synaptic loss, gliosis, and tangle formation on AD brain. Neurology 2004, 62:925\u2013931.","journal-title":"Neurology"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.291.3.358","volume":"291","author":"A. Schapira","year":"2004","unstructured":"Schapira A, Olanow C: Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 2004, 291:358\u2013364.","journal-title":"JAMA"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/156800605774962077","volume":"5","author":"R. Kleemann","year":"2005","unstructured":"Kleemann R, Kooistra T: HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Curr Drug Targets Cardiovasc Haematol Disord 2005, 5:441\u2013453.","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archneur.63.8.1085","volume":"63","author":"M. Morris","year":"2006","unstructured":"Morris M, Evans DA, Tangney C, et al.: Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol 2006, 63:1085\u20131088.","journal-title":"Arch Neurol"},{"key":"3_CR14","first-page":"898","volume":"45","author":"J.K. Liao","year":"2005","unstructured":"Liao JK, Laufs U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005, 45:898\u2013918.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K. Fassbender","year":"2001","unstructured":"Fassbender K, Simons M, Bergmann C, et al.: Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta-amyloid peptides Ab42 and Ab40 in vitro and in vivo. Proc Natl Acad Sci U S A 2001, 98:5856\u20135861.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20051129","volume":"203","author":"S. Dunn","year":"2006","unstructured":"Dunn S, Youssef S, Goldstein J, et al.: Isoprenoids determine Th1\/Th2 fate in pathogenic T cells providing a mechanism of modulation of autoimmunity by atorvastatin. J Exper Med 2006, 203:401\u2013412.","journal-title":"J Exper Med"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jalz.2006.02.003","volume":"2","author":"R.C. Green","year":"2006","unstructured":"Green RC, McNagny SE, Jayakumar P, et al.: Statin use and the risk of Alzheimer\u2019s disease: the MIRAGE Study. Alzheimer\u2019s Dementia 2006, 2:96\u2013103.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.20663","volume":"21","author":"N. Pankratz","year":"2006","unstructured":"Pankratz N, Byder L, Halter C, et al.: Presence of an APOE4 allele results in significantly earlier onset of Parkinson\u2019s disease and a higher risk with dementia. Mov Disord 2006, 21:45\u201349.","journal-title":"Mov Disord"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"32569","DOI":"10.1074\/jbc.M304553200","volume":"278","author":"H.Y. Choi","year":"2003","unstructured":"Choi HY, Karten B, Chan T, et al.: Impaired ABCA-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J Biol Chem 2003, 278:32569\u201332577.","journal-title":"J Biol Chem"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","volume":"23","author":"A. Zacco","year":"2003","unstructured":"Zacco A, Togo J, Spence K, et al.: 3-Hydroxy-3-methlglutaryl coenzyme A Reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 2003, 23:11104\u201311111.","journal-title":"J Neurosci"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P. Amarenco","year":"2006","unstructured":"Amarenco P, Bogousslavsky J, Callahan III A, et al.: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549\u2013559.","journal-title":"N Engl J Med"},{"key":"3_CR22","first-page":"e85","volume":"113","author":"T. Thom","year":"2006","unstructured":"Thom T, Haas N, Rosamond W, et al.: Heart disease and stroke statistics-2006 Update. Circulation 2006, 113:e85\u2013E151.","journal-title":"Circulation"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1161\/01.STR.0000227004.08182.bf","volume":"37","author":"D. Tanne","year":"2006","unstructured":"Tanne D, Benderly M, Goldbourt U, et al.: C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006, 37:1720\u20131724.","journal-title":"Stroke"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","volume":"352","author":"P.M. Ridker","year":"2005","unstructured":"Ridker PM, Cannon CP, Morrow D, et al.: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352:20\u201328.","journal-title":"N Engl J Med"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","volume":"363","author":"R. Collins","year":"2004","unstructured":"Collins R, Armitage J, Parish S, et al.: Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004, 363:757\u2013767.","journal-title":"Lancet"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.0000031568.40630.1C","volume":"106","author":"D.D. Waters","year":"2002","unstructured":"Waters DD, Schwartz G, Olsson A, et al.: Effects of atorvastatin on stroke in patients with unstable angina or non-q-wave myocardial infarction a myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) substudy. Circulation 2002, 106:1690\u20131695.","journal-title":"Circulation"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.WNL.0000171746.63844.6a","volume":"65","author":"M.S. Elkind","year":"2005","unstructured":"Elkind MS, Flint AC, Sciacca RR, et al.: Lipid lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 2005, 65:253\u2013258.","journal-title":"Neurology"},{"key":"3_CR28","first-page":"371","volume":"52","author":"M. McGirt","year":"2005","unstructured":"McGirt M, Woodworth G, Pradilla G, et al.: Galbraith Award: simvastatin attenuates experimental cerebral vasospasm and ameliorates serum markers of neuronal and endothelial injury in patients after subarachnooid hemorrhage: a dose-response effect dependent on endothelial nitric oxide synthase. Clin Neurosurg 2005, 52:371\u2013378.","journal-title":"Clin Neurosurg"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/str.37.2.619","volume":"37","author":"N.B. Allen","year":"2006","unstructured":"Allen NB, Brass LM, Cerese J, et al.: Use of lipid-lowering agents during acute ischemic stroke decreases in-hospital mortality. Stroke 2006, 37:619\u2013646.","journal-title":"Stroke"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/str.37.2.647","volume":"37","author":"A. Shiraishi","year":"2006","unstructured":"Shiraishi A, Niimi Y: Benefit of statin pretreatment in acute ischemic stroke. Stroke 2006, 37:647\u2013745.","journal-title":"Stroke"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.STR.0000080677.24419.88","volume":"34","author":"W. Balduini","year":"2003","unstructured":"Balduini W, Mazzoni E, Carloni S, et al.: Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1b and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke 2003, 34:2007\u20132012.","journal-title":"Stroke"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1590\/S0004-282X2005000600013","volume":"63","author":"P. Rangel","year":"2005","unstructured":"Rangel P, Cysneiros RM, Arida RM, et al.: Lovastatin reduces neuronal cell death in hippocampal CAI subfield after pilocarpine-induced status epilepticus: preliminary results. Arq Neuropsiquiatr (Brazil) 2005, 63:972\u2013976.","journal-title":"Arq Neuropsiquiatr (Brazil)"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jnr.20345","volume":"79","author":"R. Pannu","year":"2005","unstructured":"Pannu R, Barbosa E, Singh AK, et al.: Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J Neurosci Res 2005, 79:340\u2013350.","journal-title":"J Neurosci Res"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jvs.2005.08.039","volume":"42","author":"M.J. McGirt","year":"2005","unstructured":"McGirt MJ, Perler BA, Brooke BS, et al.: 3-Hydroxy-3-methylglutary coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 2005, 42:829\u2013836.","journal-title":"J Vasc Surg"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/01.STR.0000176743.67564.5d","volume":"36","author":"M. Tseng","year":"2005","unstructured":"Tseng M, Czosnyka M, Richards H, et al.: Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase ii randomized placebo-controlled trial. Stroke 2005, 36:1627\u20131632.","journal-title":"Stroke"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","volume":"24","author":"I. Bjorkhem","year":"2004","unstructured":"Bjorkhem I, Meaney S: Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004, 24:806\u2013815.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1523\/JNEUROSCI.2544-04.2005","volume":"25","author":"A. Cordle","year":"2005","unstructured":"Cordle A, Landreth G: 3-Hydroxy-3-methylgulutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses. J Neurosci 2005, 25:299\u2013307.","journal-title":"J Neurosci"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1592\/phco.23.6.726.32184","volume":"23","author":"M. Etminan","year":"2003","unstructured":"Etminan M, Gill S, S\u00e1mi A: The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies. Pharmacotherapy 2003, 23:726\u2013730.","journal-title":"Pharmacotherapy"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.10265","volume":"52","author":"R. Schmidt","year":"2002","unstructured":"Schmidt R, Schmidt H, Curb JD, et al.: Early inflammation and dementia: 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002, 52:168\u2013174.","journal-title":"Ann Neurol"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.62.5.753","volume":"62","author":"D.L. Sparks","year":"2005","unstructured":"Sparks DL, Sabbagh MN, Connor DJ, et al.: Atorvastatin for the treatment of mild to moderate alzheimer disease. Arch Neurol 2005, 62:753\u2013757.","journal-title":"Arch Neurol"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","volume":"25","author":"C.W. Shultz","year":"2005","unstructured":"Shultz CW, Rockenstein E, Crews L, et al.: Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 2005, 25:10689\u201310699.","journal-title":"J Neurosci"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.brainres.2005.03.016","volume":"1046","author":"Q. Wang","year":"2005","unstructured":"Wang Q, Wang PH, McLachlan C, et al.: Simvastatin reverses the dow nregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxy-dopamine-induced Parkinsonian rats. Brain Research 2005, 1046:229\u2013233.","journal-title":"Brain Research"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.parkreldis.2004.07.012","volume":"11","author":"A. Lieberman","year":"2005","unstructured":"Lieberman A, Lyons K, Levine J, et al.: Statins, cholesterol, co-enzyme Q10, and Parkinson\u2019s disease. Parkinsonism Related Disord 2005 11:81\u201384.","journal-title":"Parkinsonism Related Disord"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI25805","volume":"116","author":"O. Stuve","year":"2006","unstructured":"Stuve O, Youssef S, Weber MS, et al.: Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity. J Clin Invest 2006, 116:1037\u20131044.","journal-title":"J Clin Invest"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(04)16205-3","volume":"363","author":"T. Vollmer","year":"2004","unstructured":"Vollmer T, Key L, Durkalski V, et al.: Oral simvastin treatment in relapsing-remitting multiple sclerosis. Lancet 2004, 363:1607\u20131608.","journal-title":"Lancet"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.104.511964","volume":"112","author":"M. Ii","year":"2005","unstructured":"Ii M, Nishimura H, Kusano K, et al.: Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation 2005, 112:93\u2013102.","journal-title":"Circulation"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/WNL.43.1_Part_1.61","volume":"43","author":"M.B. Patterson","year":"1993","unstructured":"Patterson MB, Bisceglie AM, Higgins JJ, et al.: The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. Neurology 1993, 43:61\u201364.","journal-title":"Neurology"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/mgme.2000.2977","volume":"69","author":"G.S. Pai","year":"2000","unstructured":"Pai GS, Khan M, Barbarosa E, et al.: Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. Mol Genet Metab 2000 69:312\u2013322.","journal-title":"Mol Genet Metab"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","volume":"97","author":"J.M. McKenney","year":"2006","unstructured":"McKenney JM, Davidson MH, Jacobson TA, et al.: Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol 2006, 97:89C\u201394C.","journal-title":"Am J Cardiol"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-008-0003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-008-0003-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-008-0003-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:35:32Z","timestamp":1559417732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-008-0003-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s11883-008-0003-5","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}